STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

How 1 sources are covering this

• STATCenter·3h ago

  STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

  Whoop is yet to resolve a dispute with the FDA over a blood pressure feature, a top executive said at STAT's Breakthrough Summit.

  Read at STAT →